This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 29 2024
0mins
Source: MarketWatch
- Biotech ETFs Performance: Biotech exchange-traded funds (ETFs) are rallying in 2024, with significant gains seen in February and year-to-date.
- Small-Cap Stocks Trend: Small-cap stocks like biotech and retail are breaking out to two-year highs, indicating a potential shift in the small-cap index.
- SPDR S&P Biotech ETF: The fund has surged in performance but saw a 3.1% fall on Thursday, attracting substantial inflows in the past month.
- Small-Cap Tech Equities: Small-cap tech stocks have been underperforming compared to small-cap equities overall, suggesting a possible reversion to the mean.
- Large-Cap Tech Preference: DataTrek Research favors large-cap tech and U.S. large-cap equities over small-cap counterparts due to superior competitive advantages.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
